TheProfitWatch

LENZ - LENZ Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
27.25 2.15 (7.89%) -0.05 (-0.19%) -0.09 (-0.29%) -0.29 (-0.98%) 0.0 (0.0%) 1.71 (6.18%) 0.69 (2.56%) 0.4 (1.48%)

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.53
Diluted EPS:
-0.53
Basic P/E:
-55.4717
Diluted P/E:
-55.4717
RSI(14) 1m:
37.93
VWAP:
29.42
RVol:

Events

Period Kind Movement Occurred At

Related News